STERIS plc Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
STERIS plc (STE) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price of $219.97 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice · last filed 2026-08-07
- STERIS plc share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2026-06-30 was $219.97.
- STERIS plc share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2024-06-30 was $219.97, a 9.73% increase year-over-year.
- STERIS plc share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2023-06-30 was $200.46, a 0.08% decline year-over-year.
- STERIS plc share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2022-06-30 was $200.62.
- STERIS plc share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2026 was $245.47, a 3.60% increase from fiscal 2025.
- STERIS plc share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2025 was $236.93, a 8.82% increase from fiscal 2024.
- STERIS plc share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2024 was $217.73, a 6.08% increase from fiscal 2023.
- STERIS plc share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2023 was $205.25, a 24.32% increase from fiscal 2022.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $219.97 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | $245.47 10-K · filed 2026-05-29 | |||
| 2025-12-31 | $244.94 10-Q · filed 2026-02-06 | |||
| 2025-09-30 | $240.22 10-Q · filed 2025-11-06 | |||
| 2025-03-31 | $236.93 10-K · filed 2025-05-29 | |||
| 2024-12-31 | $237.01 10-Q · filed 2025-02-07 | |||
| 2024-09-30 | $237.49 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | $219.97 10-Q · filed 2024-08-08 | |||
| 2024-03-31 | $217.73 10-K · filed 2024-05-29 | |||
| 2023-12-31 | $199.26 10-Q · filed 2024-02-08 | |||
| 2023-09-30 | $200.46 10-Q · filed 2023-11-07 | |||
| 2023-06-30 | $200.46 10-Q · filed 2023-08-08 | |||
| 2023-03-31 | $205.25 10-K · filed 2023-05-26 | |||
| 2022-12-31 | $205.25 10-Q · filed 2023-02-08 | |||
| 2022-09-30 | $205.25 10-Q · filed 2022-11-09 | |||
| 2022-06-30 | $200.62 10-Q · filed 2022-08-08 | |||
| 2022-03-31 | $165.10 10-K · filed 2022-05-31 | |||
| 2021-12-31 | $128.11 10-Q · filed 2022-02-09 | |||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-08 | |||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 | |||
| 2021-03-31 | $121.05 10-K · filed 2021-05-28 | |||
| 2020-12-31 | $121.18 10-Q · filed 2021-02-09 | |||
| 2020-09-30 | $121.80 10-Q · filed 2020-11-06 | |||
| 2020-06-30 | $97.56 10-Q · filed 2020-08-07 | |||
| 2020-03-31 | $122.61 8-K · filed 2021-02-09 | |||
| 2019-12-31 | $102.06 10-Q · filed 2020-02-10 | |||
| 2019-09-30 | $72.57 10-Q · filed 2019-11-07 | |||
| 2019-06-30 | $72.57 10-Q · filed 2019-08-07 | |||
| 2019-03-31 | $79.91 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |